Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 901–1,000 of 1,001
Yan, J., Zhou, Y., Zheng, X., Zheng, M., Lü, J., Luo, S., Yang, D., Deng, H., Xu, W., Bi, Y., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3614 · Cited by 14
Zhou, Y., Boucsein, A., Michaels, V. R., Gray, M. K., Jefferies, C., Wiltshire, E. J., Paul, R. G., Parry‐Strong, A., Pasha, M., Petrovski, G., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16210 · Cited by 11
Availability of Open Dynamic Glycemic Data in the Field of Diabetes Research: A Scoping Review
Giudice, L. L. D., Piersanti, A., Göbl, C. S., Burattini, L., Tura, A., & Morettini, M. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251316896 · Cited by 13
Li, Y., Feng, A., Zhang, H., Wang, H., Wei, X., Wang, Z., Hou, X., & Cheng, H. (2025) · Composites Part B Engineering · doi:10.1016/j.compositesb.2025.112843 · Cited by 11
Encapsulation of Cells (Cellular Delivery) Using Sol–Gel Systems
Braun, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-055294-1.00141-0 · Cited by 16
Bietenbeck, A., Junker, R., & Luppa, P. B. (2015) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000043 · Cited by 12
Sugiyama, Y., Wakabayashi, R. H., Urasawa, M., Maruyama, Y., Shimizu, S., & Kawamata, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0140 · Cited by 12
Strollo, F., Furia, A., Verde, P., Bellia, A., Grussu, M., Mambro, A., Petrelli, M. D., & Gentile, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108638 · Cited by 14
“[7] Tamborlane WV, Beck RW, Bode BW, et al.”
BackgroundZhang, Q., & Meyerhoff, M. E. (2021) · Electroanalysis · doi:10.1002/elan.202100174 · Cited by 12
A Machine Learning Approach for Blood Glucose Level Prediction Using a LSTM Network
Gómez-Castillo, N. Y., Cajilima-Cardenaz, P. E., Zhinín-Vera, L., Maldonado-Cuascota, B., Domínguez, D. L., Pineda-Molina, G., Hidalgo-Parra, A. A., & Gonzales-Zubiate, F. A. (2022) · Communications in computer and information science · doi:10.1007/978-3-030-99170-8_8 · Cited by 14
Messer, L. H., Vigers, T., Pyle, L. L., Fivekiller, E. E., Wadwa, R. P., Hernandez, T. L., & Cook, P. F. (2022) · Diabetic Medicine · doi:10.1111/dme.14910 · Cited by 12
Suto, H., Kamei, K., Kato, H., Misawa, T., Unno, M., Nitta, H., Satoi, S., Kawabata, Y., Ohtsuka, M., Rikiyama, T., et al. (2022) · Surgery · doi:10.1016/j.surg.2022.04.031 · Cited by 11
Pitocco, D., Laurenzi, A., Tomaselli, L. G., Assaloni, R., Consoli, A., Bartolo, P. D., Guardasole, V., Lombardo, F., Maffeis, C., Rossi, A., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.07.003 · Cited by 13
Evaluating Deep Q-Learning Algorithms for Controlling Blood Glucose in In Silico Type 1 Diabetes
Tejedor, M., Hjerde, S. T. N., Myhre, J. N., & Godtliebsen, F. (2023) · Diagnostics · doi:10.3390/diagnostics13193150 · Cited by 13
“In addition, BG levels have to be monitored by the patients either several times per day using manual finger-prick measurements, or using a continuous glucose monitor (CGM) embedded in the subcutaneous tissue [8].”
MethodSocial deprivation and diabetic kidney disease: A European view
Casey, C., Buckley, C. M., Kearney, P. M., Griffin, M. D., Dinneen, S. F., & Griffin, T. P. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14156 · Cited by 13
“Technology, including continuous and fl ash glucose monitors, insulin pump, and hybrid closed loop therapy play a huge role in the management of diabetes and its bene fi ts are well reported 82 – 84 .”
BackgroundDunn, T. C., Hayter, G., Doniger, K., & Wolpert, H. A. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814532200 · Cited by 14
Landgraf, R., Kellerer, M., Aberle, J., Fach, E.-M., Gallwitz, B., Hamann, A., Joost, H., Klein, H., Müller‐Wieland, D., Nauck, M. A., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0598-0475 · Cited by 18
Martín-Vaquero, P., Martínez‐Brocca, M. A., & López, J. M. G. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.08.003 · Cited by 13
Fault Detection in Continuous Glucose Monitoring Sensors for Artificial Pancreas Systems
Yu, X., Rashid, M. M., Feng, J., Hobbs, N., Hajizadeh, I., Samadi, S., Sevil, M., Lazaro, C., Maloney, Z., & Çınar, A. (2018) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2018.09.279 · Cited by 13
Nally, L. M., Wagner, J. A., Sherr, J. L., TICHY, E. M., Weyman, K., Ginley, M. K., Zajac, K., Desousa, M., Shabanova, V., Petry, N. M., et al. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.11.017 · Cited by 11
Detecting hypoglycemia by using the brain as a biosensor
Madsen, R. E., Remvig, L. S., Beck‐Nielsen, H., & Juhl, C. B. (2011) · InTech eBooks · doi:10.5772/17018 · Cited by 12
Medical care of pregnant women with type 1 diabetes: current guidelines and clinical practice
Cyganek, K., Klupa, T., Szopa, M., Katra, B., & Malecki, M. T. (2013) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1595 · Cited by 14
Zucchini, S., Scipione, M., Balsamo, C., Maltoni, G., Rollo, A., Molinari, E., Mangoni, L., & Cicognani, A. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0080 · Cited by 13
Telemedical Artificial Pancreas
de Leiva, A., Hernando, M. E., & GBT-UPM, O. B. O. E.-H. A. (2009) · Diabetes Care · doi:10.2337/dc09-s313 · Cited by 17
Olivier, P., Lawson, M. L., Huot, C., Richardson, C., Nakhla, M. M., & Romain, J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524855 · Cited by 12
Lewis, K. R., McCrone, S., Deiriggi, P., & Bendre, S. V. (2016) · Journal for Specialists in Pediatric Nursing · doi:10.1111/jspn.12162 · Cited by 14
How Basal Insulin Analogs Have Changed Diabetes Care
Garg, S. K., & Moser, E. G. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0072 · Cited by 11
Gui, H., & Liu, J. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1802.01747 · Cited by 19
Recent Advances in the Prevention of Hypoglycemia in Type 1 Diabetes
Realsen, J., & Chase, H. P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0150 · Cited by 10
Next Generation Wellness: A Technology Model for Personalizing Healthcare
Hsueh, P.-Y. S., Chang, H., & Ramakrishnan, S. (2015) · Health informatics · doi:10.1007/978-3-319-20765-0_21 · Cited by 14
Praxisbezogene Empfehlungen zum Ambulanten Glukoseprofil
Kroeger, J., Reichel, A., Siegmund, T., & Ziegler, R. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0576-6497 · Cited by 11
DiaMeter: a Mobile Application and Web Service for Monitoring Diabetes Mellitus
Волков, И. В., & Radchenko, G. (2020) · Ural Symposium on Biomedical Engineering, Radioelectronics and Information Technology (USBEREIT) · doi:10.1109/usbereit48449.2020.9117654 · Cited by 12
Nanocoral Ag for nonenzymatic glucose detection at extremely low operational potential
Hill-Dick, J. O., Harmon, A., Cao, W., Sadasivuni, K. K., Elahi, M., Adedeji, A. V., Elsayed-Ali, H. E., Slaughter, G. E., Kumar, K., Asadi, M., et al. (2021) · Materials Today Communications · doi:10.1016/j.mtcomm.2021.102261 · Cited by 10
Alharbi, M., Albunyan, A., Nahari, A., Azmi, F. A., Alenazi, B., Harbi, T. A., Malki, M. A., & Ahmadi, H. A. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01224-0 · Cited by 11
Kovatchev, B. P., & Lobo, B. J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0117 · Cited by 10
Mader, J. K., Weinhandl, H., Köhler, G., Plank, J., Bock, G., Korsatko, S., Ratzer, M., Ikeoka, D., Köhler, H., Pieber, T. R., et al. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02924.x · Cited by 11
Hermanides, J., Engström, A. E., Wentholt, I. M. E., Sjauw, K. D., Hoekstra, J. B. L., Henriques, J. P. S., & DeVries, J. H. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0023 · Cited by 12
The Contemporary Role of Masked Continuous Glucose Monitoring in a Real-Time World
Blumer, I. R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815619182 · Cited by 10
Zekarias, K., Kumar, A. F., Moheet, A. A., & Seaquist, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.015 · Cited by 11
Marks, B. E., Waldman, G., Reardon, K., Terrio, S., Kumar, A., Stafford, D. E. J., Garvey, K. C., & Wolfsdorf, J. I. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13010 · Cited by 10
“improvement in glycemic control among pediatric patients, but did show improvement in a subset of children and adolescents who used the device at least 6 days per week.(13,14) Reports from England and Wales have found no significant benefit from insulin pump use and noted increased rates of diabetic ketoacidosis (DKA)…”
BackgroundCalhoun, P. M., Price, D. A., & Beck, R. W. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0471 · Cited by 10
Carlozzi, N. E., Choi, S. W., Wu, Z., Miner, J. A., Lyden, A. K., GRAVES, C. M., Wang, J., & Sen, S. (2021) · JMIR Research Protocols · doi:10.2196/32842 · Cited by 12
Pancreatic Insulinoma Misdiagnosed as Epilepsy for Eight Years: A Case Report and Literature Review
Ma, H., Zhang, X.-P., Zhang, Y., Lu, H., Wang, J.-T., Zhang, Y., & Wu, X. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3708 · Cited by 11
“The CGMS provides ongoing measurements of the interstitial glucose levels (7) and is especially useful in patients with unawareness and/or frequent episodes of hypoglycemia (8).”
BackgroundContinuous Glucose Monitoring in Children and Adolescents
Slover, R. H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0303-6 · Cited by 10
Benefits of Blinded Continuous Glucose Monitoring during a Randomized Clinical Trial
Muchmore, D. B., Sharp, M., & Vaughn, D. E. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500321 · Cited by 10
Albrecht, D., Puder, J. J., Keller, U. B., & Zulewski, H. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03260.x · Cited by 11
Can Improved Glycemic Control Slow Renal Function Decline at All Stages of Diabetic Nephropathy?
Goel, G., & Perkins, B. A. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.004 · Cited by 12
McAuley, S. A., Dang, T. T., Horsburgh, J. C., Bansal, A., Ward, G. M., Aroyan, S., Jenkins, A. J., MacIsaac, R. J., Shah, R. V., & O'Neal, D. N. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816629982 · Cited by 11
Inzucchi, S. E., & Sherwin, R. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00236-0 · Cited by 12
Multiboronic acid-conjugated chitosan scaffolds with glucose selectivity to insulin release
Siddiqui, N. A., Billa, N., & Roberts, C. J. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1301774 · Cited by 10
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Ga, F., & Heinemann, L. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.10.9 · Cited by 10
Clinical Experience with Continuous Glucose Monitoring in Adults
Fabiato, K., Buse, J. B., Duclos, M., Largay, J. F., Izlar, C., O'Connell, T., Stallings, J. E., & Dungan, K. M. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0004 · Cited by 10
The Future of Continuous Glucose Monitoring
Garg, S. K. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0105 · Cited by 17
Cutaneous adverse events related to FreeStyle Libre device
Brahimi, N., Potier, L., & Mohammedi, K. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30896-6 · Cited by 11
Continuous Glucose Monitoring for the Internist
Lee, G. S., & Lupsa, B. C. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.004 · Cited by 13
Molecular profiling of NOD mouse islets reveals a novel regulator of insulitis onset
Mathisen, A. F., Vacaru, A. M., Unger, L., Lamba, E. M., Mardare, O.-A.-M., Daian, L. M., Ghila, L., Vacaru, A. M., & Chera, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-65454-x · Cited by 9
Unger, J., & Parkin, C. G. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2306 · Cited by 10
Maiorino, M. I., Petrizzo, M., Bellastella, G., & Esposito, K. (2017) · Endocrine · doi:10.1007/s12020-017-1328-z · Cited by 11
Abraham, M. B., Heels, K., Nicholas, J. A., Cole, C., Gebert, R., Klimek, J., Jopling, T., Ambler, G. R., Cameron, F. J., Davis, E. A., et al. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817752188 · Cited by 11
Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management
VanBaak, K., Nally, L. M., Finigan, R. T., Jurkiewicz, C., Burnier, A., Conrad, B., Khodaee, M., & Lipman, G. S. (2019) · Wilderness and Environmental Medicine · doi:10.1016/j.wem.2019.10.003 · Cited by 9
Pangrace, M., Dolan, S., Grace, T., Greene, E., Long, E., McClelland, S., Moore, J., Morgan, D. E., Mullins, H., & Wescott, S. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.1-a.s1 · Cited by 9
Modern clinical management helps reducing the impact of type 1 diabetes in children
Scaramuzza, A. E., & Zuccotti, G. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.001 · Cited by 9
“Combining CGM and continuous subcutaneous insulin infusion CSII), a now well-established way to insulin delivery [5], provides more useful tool for patients with type 1 diabetes, the sensorugmented pump (SAP).”
BackgroundMethodInfluentialZheng, H., Nathan, D. M., & Schoenfeld, D. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0199 · Cited by 9
Nudell, J., Slade, A., Jovanovič, L., & Hod, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02579.x · Cited by 12
Price, D. A., Graham, C., Parkin, C. G., & Peyser, T. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815607863 · Cited by 10
Management of Diabetes in Children
Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 13
Shetage, S. S., Traynor, M. J., Brown, M. B., Galliford, T. M., & Chilcott, R. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-09014-6 · Cited by 9
de Valk, H. W., Lablanche, S., Bosi, E., Choudhary, P., Silva, J. D., Castañeda, J., Vorrink, L., de Portu, S., & Cohen, O. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0222 · Cited by 9
Yamamoto, Y., Kikuchi, T., Urakami, T., Goto, M., Tsubouchi, K., Sasaki, G., Mizuno, H., Abe, Y., Kitsuda, K., Amemiya, S., et al. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0329 · Cited by 10
Yang, X., Deng, H., Zhang, X., Yang, D., Yan, J., Yao, B., Weng, J., & Xu, W. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9530-3 · Cited by 9
Reliability of real‐time continuous glucose monitoring in infants
Tomotaki, S., Toyoshima, K., Shimokaze, T., & Kawai, M. (2019) · Pediatrics International · doi:10.1111/ped.13961 · Cited by 9
Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring
Larkin, M., Nathan, D. M., Bebu, I., Krause-Steinrauf, H. J., Herman, W. H., Higgins, J. M., Tiktin, M., Cohen, R. M., Lund, C., Bergenstal, R. M., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0202 · Cited by 9
Has subsidized continuous glucose monitoring improved outcomes in pediatric diabetes?
Swaney, E. E. K., McCombe, J., Coggan, B., Donath, S. M., O’Connell, M. A., & Cameron, F. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13106 · Cited by 10
The role of continuous glucose monitoring in pregnancy
Li, A., & Brackenridge, A. (2021) · Obstetric Medicine · doi:10.1177/1753495x211014716 · Cited by 11
Sperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 13
Decision Support Systems and Closed‐Loop
Nimri, R., Phillip, M., & Kovatchev, B. P. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.2504 · Cited by 9
A centennial review of discoveries and advances in diabetes: Children and youth
Mistry, S., Tonyushkina, K. N., Benavides, V. C., Choudhary, A., Huerta‐Saenz, L., Patel, N. S., Mahmud, F. H., Libman, I. M., & Sperling, M. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13392 · Cited by 14
Predictors of Parental Interest in Continuous Glucose Monitoring for Children with Type 1 Diabetes
Kashmer, L., Clarke, W., Gurka, M. J., Elchuri, S. V., Nyer, M., & Gonder-Frederick, L. A. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0100 · Cited by 12
Thomas, A., & Heinemann, L. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600312 · Cited by 10
Sun, R., Banerjee, I., Sang, S., Joseph, J., Schneider, J. A., & Hernandez‐Boussard, T. (2021) · Clinical Diabetes · doi:10.2337/cd20-0098 · Cited by 10
Impact of continuous glucose monitoring in youth with type 1 diabetes aged 15–21 years
Lee, M. A., Holmes-Walker, D. J., Farrell, K., & Clark‐Luccitti, A. (2022) · Internal Medicine Journal · doi:10.1111/imj.15347 · Cited by 10
Bioelectronic Sensing of Insulin Demand
Raoux, M., Bontorin, G., Bornat, Y., Lang, J., & Renaud, S. (2011) · Wiley eBooks · doi:10.1002/9783527639366.ch11 · Cited by 12
Abstract 14: Gonadal Dysgenesis with Mayer Rokitansky Küster Hauser Syndrome A Case Report
Sharma, D., Mathur, S., Sharma, B., & Saran, S. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.129714 · Cited by 9
A Primary Care Perspective on the Use of Continuous Glucose Monitoring in Clinical Practice
Bhide, M., Grey, J. M. S., Moser, E. G., & Garg, S. K. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0169 · Cited by 9
Continuous Glucose Monitoring Adoption in the United Kingdom – An Economic and Policy Perspective
Oliver, N. S. (2017) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2017.13.02.73 · Cited by 10
Cichosz, S. L., Kronborg, T., Hangaard, S., Vestergaard, P., & Jensen, M. H. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0102 · Cited by 10
Cichosz, S. L., Hangaard, S., Kronborg, T., Vestergaard, P., & Jensen, M. H. (2025) · PeerJ · doi:10.7717/peerj.19501 · Cited by 9
Martens, T. W., Beck, R. W., Griffen, C., Di, J., Elkind-Hirsch, K. E., Johnson, M. L., Castle, J. R., Beck, S. E., & Bergenstal, R. M. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005469 · Cited by 10
Ehrhardt, N. M., Fonda, S. J., Mandava, P., ABDALLA, G., & Fay, E. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101878 · Cited by 10
Mohamed, I. A., Fisher, A., Cooper, P., & Hussain, S. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0576-8 · Cited by 8
Zhang, L., Xu, Y., Jiang, X., Wu, J., Liu, F., Fan, L., Li, X., Yin, G., & Yang, L. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13693 · Cited by 8
Miller, K. M., Bauza, C. E., Kanapka, L. G., Clements, M. A., DeSalvo, D. J., Hood, K. K., Messer, L. H., Sherr, J. L., Bergamo, K., Criego, A. B., et al. (2023) · Pediatric Diabetes · doi:10.1155/2023/6718115 · Cited by 9
Song, J., McNeany, J., Wang, Y., Daley, T. C., Stecenko, A. A., & Kamaleswaran, R. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109255 · Cited by 8
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., & Shalitin, S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.2509 · Cited by 8
Miele, A., Weiland, K., & Dungan, K. M. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0081 · Cited by 8
Martín-Vaquero, P., Martínez‐Brocca, M. A., & López, J. M. G. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.07.002 · Cited by 13
Continuous glucose monitoring in pregnant women with type 1 diabetes
Garg, S. K., & Polsky, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32449-2 · Cited by 8
A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes
Galderisi, A., & Sherr, J. L. (2019) · Pediatric Annals · doi:10.3928/19382359-20190725-03 · Cited by 8
Self‐management among pre‐teen and adolescent diabetes device users
Faulds, E. R., Hoffman, R. P., Grey, M. J., Tan, A., Tubbs‐Cooley, H. L., Militello, L. K., & Happ, M. B. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13131 · Cited by 10
Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insulin infusion
Pinheiro, S. L., Bastos, M., Barros, L. M., Melo, M., & Paiva, I. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01827-2 · Cited by 9
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.